首页> 美国卫生研究院文献>Antioxidants Redox Signaling >S-Nitrosylation of Dynamin-Related Protein 1 Mediates Mutant Huntingtin-Induced Mitochondrial Fragmentation and Neuronal Injury in Huntingtons Disease
【2h】

S-Nitrosylation of Dynamin-Related Protein 1 Mediates Mutant Huntingtin-Induced Mitochondrial Fragmentation and Neuronal Injury in Huntingtons Disease

机译:动力相关蛋白1的S-亚硝基化介导亨廷顿氏病中突变的亨廷顿诱导线粒体片段化和神经元损伤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aims: Dynamin-related protein1 (Drp1) is a large GTPase that mediates mitochondrial fission. We recently reported in Alzheimer's disease (AD) that S-nitrosylation of Drp1 (forming S-nitroso [SNO]-Drp1) results in GTPase hyperactivity and mitochondrial fragmentation, thus impairing bioenergetics and inducing synaptic damage and neuronal loss. Here, since aberrant mitochondrial dynamics are also key features of Huntington's disease (HD), we investigated whether formation of SNO-Drp1 contributes to the pathogenesis of HD in cell-based and animal models. >Results: We found that expression of mutant huntingtin (mutHTT) protein in primary cultured neurons triggers significant production of nitric oxide (NO). Consistent with this result, increased levels of SNO-Drp1 were found in the striatum of a transgenic mouse model of HD as well as in human postmortem brains from HD patients. Using specific fluorescence markers, we found that formation of SNO-Drp1 induced excessive mitochondrial fragmentation followed by loss of dendritic spines, signifying synaptic damage. These neurotoxic events were significantly abrogated after transfection with non-nitrosylatable mutant Drp1(C644A), or by the blocking of NO production using an nitric oxide synthase inhibitor. These findings suggest that SNO-Drp1 is a key mediator of mutHTT toxicity, and, thus, may represent a novel drug target for HD. >Innovation and Conclusion: Our findings indicate that aberrant S-nitrosylation of Drp1 is a prominent pathological feature of neurodegenerative diseases such as AD and HD. Moreover, the SNO-Drp1 signaling pathway links mutHTT neurotoxicity to a malfunction in mitochondrial dynamics, resulting in neuronal synaptic damage in HD. Antioxid. Redox Signal. 19, 1173–1184.
机译:>目的:动力蛋白相关蛋白1(Drp1)是一种大的GTP酶,介导线粒体裂变。我们最近在阿尔茨海默氏病(AD)中报道,Drp1的S-亚硝基化(形成S-亚硝基[SNO] -Drp1)导致GTPase过度活跃和线粒体断裂,从而削弱了生物能,并导致突触损伤和神经元丢失。在这里,由于线粒体动力学异常也是亨廷顿舞蹈病(HD)的关键特征,因此我们研究了SNO-Drp1的形成是否在基于细胞和动物的模型中促进了HD的发病。 >结果:我们发现,原代培养的神经元中突变亨廷顿蛋白(mutHTT)的表达触发了一氧化氮(NO)的大量产生。与该结果一致的是,在转基因HD小鼠模型的纹状体以及HD患者的人类死后大脑中发现SNO-Drp1水平升高。使用特定的荧光标记,我们发现SNO-Drp1的形成诱导线粒体过度断裂,继而丢失树突棘,表明突触损伤。用非亚硝基糖基化突变体Drp1(C644A)转染后,或使用一氧化氮合酶抑制剂阻断NO产生后,这些神经毒性事件被明显消除。这些发现表明SNO-Drp1是mutHTT毒性的关键介质,因此可能代表HD的新型药物靶标。 >创新和结论:我们的发现表明,Drp1的S-亚硝基化异常是神经退行性疾病(如AD和HD)的突出病理特征。此外,SNO-Drp1信号通路将mutHTT神经毒性与线粒体动力学失灵联系起来,导致高清神经元突触损伤。抗氧化。氧化还原信号。 19,1173–1184。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号